Lymphoma Small Lymphocytic
📧 Sign up to get email alerts when something new happens for Lymphoma Small Lymphocytic.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma [Phase 2]
Phase 2 safety and effectiveness study of a vaccine therapy in indolent lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Phase 2]
Phase 2 trial evaluating lenalidomide with low-dose dexamethasone and rituximab in rituximab-resistant, non-aggressive B-cell lymphomas; com…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 dose-ranging study evaluated pixantrone in the FND-R regimen for indolent non-Hodgkin lymphoma; the trial has completed.